SMS Pharma gains on EIR from USFDA
16 Mar 2020

SMS Pharmaceuticals rose 1.74% to Rs 35 after it received an establishment inspection report (EIR) from US drug regulator for its Andhra Pradesh-based API facility.

https://www.business-standard.com/article/news-cm/sms-pharma-gains-on-eir-from-usfda-120031200248_1.html